Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evommune (EVMN) Prepaid Assets (2024 - 2025)

Evommune (EVMN) has disclosed Prepaid Assets for 2 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 119.61% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, up 119.61% year-over-year, with the annual reading at $4.3 million for FY2025, 119.61% up from the prior year.
  • Prepaid Assets for Q4 2025 was $4.3 million at Evommune, down from $5.9 million in the prior quarter.
  • The five-year high for Prepaid Assets was $5.9 million in Q3 2025, with the low at $1.9 million in Q4 2024.